Clinical Trials

50 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02467868 2022-02-14

Efficacy and Safety Study With MYL-1401H and Neulasta

BreastClassical hematology

193 enrolled

Breast Neoplasms, Neutropenia, Chemotherapy-Induced Febrile Neutropenia

NCT02841722 2020-06-24

EMEG-E-01

Phase NA Completed

95 enrolled

Breast Neoplasms

NCT02124148 2020-04-01

A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer

Phase 1 Completed

167 enrolled

BreastGastrointestinal

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT00513695 2019-08-07

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

68 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00002836 2018-11-06

Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer

184 enrolled

Breast Neoplasms

NCT00194779 2018-03-12

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

50 enrolled 13 charts

Breast Neoplasms

NCT00404066 2017-12-22

Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer

21 enrolled 11 charts

Breast Neoplasms

NCT02173262 2017-11-06

OTT14-03

Phase 4 Completed

142 enrolled

Breast Neoplasms

NCT00407888 2017-08-31

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

60 enrolled 11 charts

Breast Neoplasms

NCT00590785 2017-08-25

Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

60 enrolled

Breast Neoplasms

NCT00615602 2015-03-04

Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer

489 enrolled

Breast Neoplasms

NCT00119262 2014-05-15

Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

226 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01985724 2014-05-14

Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer

650 enrolled

Breast Neoplasms

NCT00049114 2013-06-06

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

62 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00016406 2013-01-24

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

399 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00007904 2012-10-02

Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

16 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00005800 2012-09-25

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

45 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00194753 2012-09-13

Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12

80 enrolled

Breast Neoplasms

NCT00002837 2012-07-31

High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer

Phase 1/2 Completed

21 enrolled

Breast Neoplasms

NCT00001384 2008-03-04

A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients

35 enrolled

Breast Neoplasms

NCT00431080 2008-01-21

Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer

478 enrolled

Breast Neoplasms

NCT00194740 2007-12-06

Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer

48 enrolled